Skip to main content

TMS Offers Promising Results For Memory Loss Treatment

Chicago, IL (Newsworthy.ai) Tuesday Apr 25, 2023 @ 1:00 PM Central —

A new treatment for memory loss has been introduced, giving hope to patients and their families. Transcranial magnetic stimulation (TMS) offers promising results in slowing the condition's progression, which can cause a decline in memory and thinking skills.

As people age, changes in cognitive function are regular. However, for some people, these changes can lead to a more severe condition, memory loss. While there is no known cure for the disease, treatments such as TMS are now available.

TMS is a non-invasive and painless treatment that uses magnetic fields to stimulate nerve cells in the brain. TMS has shown promising results in slowing the progression of memory loss. It works by stimulating the area of the brain responsible for memory and thinking. This stimulation can help slow the decline in cognitive function commonly associated with memory loss.

Before the treatment, patients experience significant memory loss and difficulty with attention and focus. After only a few sessions of TMS, they will notice significant improvements in their memory and overall cognitive function.

TMS is an FDA-approved treatment that has been used in the past to treat depression and anxiety. It has a low risk of side effects and requires no anesthesia. Treatment sessions are painless and typically last less than an hour.

Through TMS treatment, Able psychiatry can help individuals with memory loss to slow the progression of this debilitating condition.

About Able Psychiatry

Able Psychiatry is a psychiatry practice in Lincoln Park / Lakeview, Chicago. Thoughtful psychiatric treatment. TMS is available for the treatment of refractory depression. Ketamine treatment is available for those who pass a brief screening.



This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.